India, July 8 -- Hyderabad-based Sai Parenterals has announced the successful completion of a Rs 50 crore equity investment round by a group of marquee investors. The capital will support the company's growth plans for establishing its international footprint as it pursues its vision to become a global pharmaceutical company.

Samarsh Capital, Vyom Partners, and funds associated with Blue Lotus Capital led the fundraising round.

Anil Karusala, Managing Director of Sai Parenterals, remarked, "We are working diligently to build a world-class pharmaceutical company that adheres to the highest global standards and practices. This equity infusion will allow us to acquire high-potential international assets and intellectual property in regulat...